Renalytix Plc Stock Börse Stuttgart
Stocks
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0395 EUR | +16.18% |
|
+38.60% | -34.71% |
| 07-06 | WINNERS & LOSERS: Knights profit up; GoldStone raises GBP3.5 million | AN |
| 06-30 | WINNERS & LOSERS: Defence Holdings jumps; ADM Energy delays results | AN |
| Market Cap | 13.34M 11.54M 10.77M 9.88M 18.59M 1.27B 18.88M 126M 49.61M 636M 50.08M 48.98M 2.1B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 15.51M 14.49M 13.29M 25M 1.71B 25.4M 170M 66.72M 856M 67.35M 65.88M 2.83B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
73.31% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +38.60% | ||
| Current month | +38.60% | ||
| 1 month | +33.90% | ||
| 3 months | +229.17% | ||
| 6 months | -37.30% | ||
| Current year | -34.71% |
| 1 week | 0.03 |  | 0.04 |
| 1 month | 0.03 | | 0.04 |
| 3 years | 0.01 | | 1.31 |
| 5 years | 0.01 | | 12 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 2018-03-14 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 2024-05-27 |
Howard Doran
PSD | President | 65 | 2024-04-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baines
CHM | Chairman | 62 | 2024-11-04 |
James McCullough
BRD | Director/Board Member | 58 | 2018-03-14 |
| Chairman | 74 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.18% | +38.60% | -45.52% | -96.68% | 21.82M | |
| +1.18% | +6.51% | +29.58% | -34.28% | 16.86B | |
| +4.02% | -1.28% | -8.53% | +110.43% | 1.75B | |
| -24.72% | -26.74% | -49.65% | -85.36% | 838M | |
| +2.21% | +2.13% | -35.85% | +26.06% | 1.01B | |
| +2.52% | +3.63% | -42.40% | -49.22% | 679M | |
| +3.27% | +0.84% | -46.45% | -50.17% | 548M | |
| +1.31% | +10.90% | +58.90% | -45.35% | 523M | |
| +4.95% | +10.97% | -44.88% | -45.37% | 417M | |
| +3.11% | +3.53% | -8.74% | -24.18% | 384M | |
| Average | -0.24% | +3.40% | -19.36% | -29.41% | 2.56B | |
| Weighted average by Cap. | +0.69% | +5.01% | +15.61% | -23.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 1.98 1.85 1.7 3.19 217.85 3.24 21.69 8.51 109.19 8.6 8.41 360.98 | 3 2.59 2.42 2.22 4.18 285.52 4.25 28.43 11.16 143.11 11.27 11.02 473.11 |
| Net income | -33.46M -28.94M -27.03M -24.79M -46.63M -3.18B -47.37M -317M -124M -1.6B -126M -123M -5.28B | -20.4M -17.65M -16.48M -15.12M -28.43M -1.94B -28.88M -193M -75.88M -973M -76.61M -74.93M -3.22B |
| Net Debt | 3.86M 3.33M 3.11M 2.86M 5.37M 367M 5.46M 36.53M 14.34M 184M 14.48M 14.16M 608M | 4.6M 3.98M 3.72M 3.41M 6.41M 438M 6.51M 43.6M 17.11M 219M 17.27M 16.9M 725M |
Employees
-
| Date | Price | Change |
|---|---|---|
| 26-08-07 | €0.0395 | +16.18% |
| 26-08-06 | €0.0340 | 0.00% |
| 26-08-05 | €0.0340 | +6.25% |
| 26-08-04 | €0.0320 | +8.47% |
| 26-08-03 | €0.0295 | +3.51% |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
- 2O9 Stock
Select your edition
All financial news and data tailored to specific country editions
